Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2017
18th World Conference on Lung Cancer
Access to all presentations that occur during the 18th World Conference on Lung Cancer in Yokohama, Japan
Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Download PDF of the Conference Program: Click Here.
Presentations will be available 24 hours after their live presentation time
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
-
+
MTE 16 - Technical Issues after Neoadjuvant Chemoradiation - Surgeon's Perspective (Sign Up Required)
- Type: Meet the Expert
- Track: Surgery
- Presentations: 2
- Coordinates: 10/17/2017, 07:00 - 08:00, Room 311 + 312
-
+
MTE 16.01 - Difficulties of Surgery After Induction of Chemoradiotherapy
07:00 - 07:30 | Presenter: Eric Vallieres
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MTE 16.02 - Surgery for Stage IIIA NSCLC - Surgeon's Perspective
07:30 - 08:00 | Presenter: Gail Elizabeth Darling
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE 17 - Neuroendocrine Tumor (Sign Up Required)
- Type: Meet the Expert
- Track: SCLC/Neuroendocrine Tumors
- Presentations: 2
- Coordinates: 10/17/2017, 07:00 - 08:00, Room 418
-
+
MTE 17.01 - Pathological Features of Neuroendocrine Tumors
07:00 - 07:30 | Presenter: Yuichi Ishikawa
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MTE 17.02 - Surgical Strategy for the Treatment of Neuroendocrine Tumors
07:30 - 08:00 | Presenter: Enrico Ruffini
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE 18 - Treatment for Squamous Cell Carcinoma (Sign Up Required)
- Type: Meet the Expert
- Track: Advanced NSCLC
- Presentations: 1
- Coordinates: 10/17/2017, 07:00 - 08:00, Room 313 + 314
-
+
MTE 18.01 - Treatment for Squamous Cell Carcinoma
07:00 - 08:00 | Presenter: Paul K. Paik
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE 19 - Laser Therapy for Early Stage and Airway Obstruction (Sign Up Required)
- Type: Meet the Expert
- Track: Pulmonology/Endoscopy
- Presentations: 2
- Coordinates: 10/17/2017, 07:00 - 08:00, Room 317
-
+
MTE 19.01 - Laser Therapy for Airway Obstruction
07:00 - 07:30 | Presenter: Kenneth Kazuto Sakata
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MTE 19.02 - Ablative Therapy for Early Stage Lung Cancer
07:30 - 08:00 | Presenter: Antoni Rosell
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE 20 - Liquid Biopsy (Sign Up Required)
- Type: Meet the Expert
- Track: Biology/Pathology
- Presentations: 2
- Coordinates: 10/17/2017, 07:00 - 08:00, Room 303 + 304
-
+
MTE 20.01 - Recent Advances in Liquid Biopsy
07:00 - 07:30 | Presenter: Daniel SW Tan
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MTE 20.02 - Recent Advances in Liquid Biopsy
07:30 - 08:00 | Presenter: Geoffrey R. Oxnard
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE 21 - Search for Novel Driver Mutations (Sign Up Required)
- Type: Meet the Expert
- Track: Chemotherapy/Targeted Therapy
- Presentations: 2
- Coordinates: 10/17/2017, 07:00 - 08:00, Room 315
-
+
MTE 21.01 - Novel Driver Mutations for Lung Cancer
07:00 - 07:30 | Presenter: Koichi Goto
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MTE 21.02 - New Molecular Diagnosis Platforms for Clinicians
07:30 - 08:00 | Presenter: Marc Ladanyi
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
SH 01 - WCLC 2017 Highlights of the Previous Day
- Type: Scientific Highlights
- Track: Advanced NSCLC
- Presentations: 3
- Coordinates: 10/17/2017, 07:00 - 08:00, Room 502
-
+
SH 01.01 - Advanced NSCLC, Clinical Design, Statistics and Clinical Trials, Immunology and Immunotherapy and Patient Advocacy
07:00 - 07:20 | Presenter: Suresh S Ramalingam
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SH 01.02 - Surgery
07:20 - 07:40 | Presenter: Masafumi Kawamura
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SH 01.03 - Biology/Pathology and Epidemiology/Primary Prevention/Tobacco Control and Cessation
07:40 - 08:00 | Presenter: Y. Takiguchi
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
SH 02 - WCLC 2017 Highlights of the Previous Day
- Type: Scientific Highlights
- Track: Biology/Pathology
- Presentations: 3
- Coordinates: 10/17/2017, 07:00 - 08:00, Room 503
-
+
SH 02.01 - Chemotherapy/Targeted Therapy and SCLC/Neuroendocrine Tumors
07:00 - 07:20 | Presenter: Robert Pirker
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SH 02.02 - Radiotherapy
07:20 - 07:40 | Presenter: Sung-Ja Ahn
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SH 02.03 - Biology/Pathology, Mesothelioma and Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
07:40 - 08:00 | Presenter: Yuko Minami
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
PL 02 - Presidential Symposium including Top 3 Abstracts and James Cox Lectureship Award Presentation
- Type: Plenary Session
- Track: Early Stage NSCLC
- Presentations: 8
- Moderators:Hisao Asamura
- Coordinates: 10/17/2017, 08:15 - 09:45, Plenary Hall (Exhibit Hall D)
-
+
PL 02.01 - Introduction and Welcome
08:15 - 08:20
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL 02.02 - Patient-Reported Outcomes with Durvalumab after Chemoradiation in Locally Advanced, Unresectable NSCLC: Data from PACIFIC
08:20 - 08:30 | Presenter: R. Hui
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL 02.03 - Discussant - PL 02.02
08:30 - 08:40 | Presenter: Michael Boyer
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL 02.04 - SCAT Ph III Trial: Adjuvant CT Based on BRCA1 Levels in NSCLC N+ Resected Patients. Final Survival Results a Spanish Lung Cancer Group Trial
08:40 - 08:50 | Presenter: Bartomeu Massuti
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL 02.05 - Discussant - PL 02.04
08:50 - 09:00 | Presenter: Joan Schiller
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL 02.06 - The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for R Status Descriptors for Non-Small Cell Lung Cancer
09:00 - 09:10 | Presenter: John G Edwards
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL 02.07 - Discussant - PL 02.06
09:10 - 09:20 | Presenter: Kemp Kernstine
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL 02.08 - James Cox Lectureship Award Presentation
09:20 - 09:45 | Presenter: James D. Cox
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.01 - Advanced NSCLC
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
- Presentations: 83
- Coordinates: 10/17/2017, 09:00 - 16:00, Exhibit Hall (Hall B + C)
-
+
P2.01-001 - Serum Albumin Level Predicts the Survival Benefit of Chemotherapy in Elderly Advanced NSCLC Patients with Poor Performance Status
09:00 - 09:00 | Presenter: Satoshi Ikeda
- Abstract
Loading... -
+
P2.01-002 - Survival of Patients with Advanced Non-Small Cell Lung Cancer at Single Institute in Eastern Thailand, 2013-2016
09:00 - 09:00 | Presenter: Sitthi Sukauichai
- Abstract
Loading... -
+
P2.01-003 - Does Astragalus Membranaceus Root Extract Have Any Survival Benefit for Metastatic Non-Small Cell Lung Cancer?
09:00 - 09:00 | Presenter: Adnan Aydiner
- Abstract
Loading... -
+
P2.01-004 - Safety and Efficacy of Nab-Paclitaxel plus Carboplatin in Elderly Patients with NSCLC (ABOUND.70+)
09:00 - 09:00 | Presenter: Corey J Langer
- Abstract
Loading... -
+
P2.01-005 - A Randomized Phase II Trial of Erlotinib vs S-1 in Patients with NSCLC as Third- or Fourth-Line Therapy (HOT1002)
09:00 - 09:00 | Presenter: Yasutaka Kawai
- Abstract
Loading... -
+
P2.01-006 - Effect of Maintenance Using Pemetrexed with and without Bevacizumad in Patients Advanced Lung Cancer in Non-Small Cells
09:00 - 09:00 | Presenter: Mayra Galeana Hernandez
- Abstract
Loading... -
+
P2.01-007 - Molecular Characterization of Non-Small Cell Lung Cancers (NSCLC) in Young Patients from an Argentine Population
09:00 - 09:00 | Presenter: Valeria Cecilia Denninghoff
- Abstract
Loading... -
+
P2.01-008 - Combination of Bavacizumab with Conventional Chemotherapy Shows Better Prognosis in Patients with Lung Cancer with Liver Metastasis
09:00 - 09:00 | Presenter: Kim Ki-Up
- Abstract
Loading... -
+
P2.01-009 - The Efficacy of Bevacizumab Adding in Standard First Line Chemotherapy and Maintenance Treatment in Advanced NSCLC: A Network Meta-Analysis
09:00 - 09:00 | Presenter: Voralak Vichapat
- Abstract
Loading... -
+
P2.01-010 - Risk Score for Predicting Acute Exacerbation after Chemotherapy in Lung Cancer Associated with Interstitial Pneumonia
09:00 - 09:00 | Presenter: Kazutoshi Isobe
- Abstract
Loading... -
+
P2.01-011 - The Efficiency and Safety of Apatinib plus S-1 as Second-Line or Laterline Chemotherapy for Advanced Squamous Cell Lung Carcinoma
09:00 - 09:00 | Presenter: Qingming Shi
- Abstract
Loading... -
+
P2.01-012 - Impact of Brain Metastases on the Humanistic Burden Incurred by Patients with Advanced Non-small Cell Lung Cancer (A-nsclc)
09:00 - 09:00 | Author(s): G. Taylor-Stokes
- Abstract
Loading... -
+
P2.01-013 - Nab-Paclitaxel/Carboplatin in Elderly Patients with NSCLC (ABOUND.70+): Analysis of Safety and Quality of Life (QoL) by Cycle
09:00 - 09:00 | Author(s): E. Kim
- Abstract
Loading... -
+
P2.01-014 - ABOUND.PS2: Safety and Efficacy of Nab-Paclitaxel–Based Therapy in Patients with NSCLC and ECOG PS 2
09:00 - 09:00 | Presenter: Ajeet Gajra
- Abstract
Loading... -
+
P2.01-015 - Longitudinal Assessment of Performance Status (PS) in Patients with NSCLC and ECOG PS 2 on Nab-Paclitaxel–Based Therapy
09:00 - 09:00 | Presenter: Nagla Abdel Karim
- Abstract
Loading... -
+
P2.01-016 - Prognostic Impact of a New Score Using Neutrophil-To-Lymphocyte Ratios in the Serum and Malignant Pleural Effusion in Lung Cancer Patients
09:00 - 09:00 | Presenter: Hae-Seong Nam
- Abstract
Loading... -
+
P2.01-017 - Study on the Effect of Apatinib Salvage Treatment of Advanced Non-Small Cell Lung Cancer
09:00 - 09:00 | Author(s): Z. Xu
- Abstract
Loading... -
+
P2.01-018 - Risk Factors in Patients with Pathological N1 or N2 Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: Yoshimasa Tokunaga
- Abstract
Loading... -
+
P2.01-019 - The Necessity of Contrast-enhanced CT before CT-Guided Percutaneous Transthoracic Needle Biopsy for Lung Lesions
09:00 - 09:00 | Presenter: Tang Feng Lv
- Abstract
Loading... -
+
P2.01-020 - Continuous Intravenous Infusion Endostar Combined with Pemetrexed plus Cisplatin in Chinese Treatment-Naïve Metastatic Non-Squamous NSCLC
09:00 - 09:00 | Presenter: Li Chen
- Abstract
Loading... -
+
P2.01-021 - Efficacy of Single-Agent Chemotherapy after Exposure to Nivolumab in Advanced Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: Yuto Yasuda
- Abstract
Loading... -
+
P2.01-022 - Nintedanib/Docetaxel Efficacy in Advanced Lung Adenocarcinoma Treated with 1L Chemotherapy/2L Immunotherapy in Nintedanib NPU
09:00 - 09:00 | Presenter: Jesus Corral
- Abstract
Loading... -
+
P2.01-023 - Reasons for Withholding Systemic Therapy in Stage IV NSCLC: Comparison of Years 2004 to 2007 and 2010 to 2013
09:00 - 09:00 | Presenter: Gouri Shankar Bhattacharyya
- Abstract
Loading... -
+
P2.01-024 - Prognostic Value of Body Fat Mass Ratio in Lung Cancer Patients
09:00 - 09:00 | Author(s): N. Akdeniz
- Abstract
Loading... -
+
P2.01-025 - Evaluation of Calculating Carboplatin Dosage in Carboplatin–Pemetrexed Therapy in Chinese Patients with Advanced NSCLC
09:00 - 09:00 | Presenter: Yixiang Zhu
- Abstract
Loading... -
+
P2.01-026 - Distribution of Metastatic Disease in Survival Outliers with Stage IV Non-Small Cell Lung Cancer
09:00 - 09:00 | Author(s): A. Fung
- Abstract
Loading... -
+
P2.01-027 - Clinical Significance of Topoisomerase-II Expression in Patients with Non-Small Cell Lung Cancer Treated with Amrubicin
09:00 - 09:00 | Presenter: Reiko Sakurai
- Abstract
Loading... -
+
P2.01-028 - Clinical Correlation between CTCs Enumeration Based on New Detection Method and Chemotherapy Efficacy in Human Advanced Lung Cancer
09:00 - 09:00 | Presenter: Honglei Chen
- Abstract
Loading... -
+
P2.01-029 - Real World Report of Clinical Outcomes of Bevacizumab in First-Line or Later-Line Treatment for Patients with Advanced NSCLC
09:00 - 09:00 | Presenter: Yalei Wang
- Abstract
Loading... -
+
P2.01-030 - Real World Study of Bevacizumab-Contained Regimen as First Line Therapy in Chinese Patients with Advanced NSCLC
09:00 - 09:00 | Presenter: Yuxin Mu
- Abstract
Loading... -
+
P2.01-031 - Use of Geriatric Assessment (GA) in Clinical Practice for Stage IV Non-Small Cell Lung Cancer (NSCLC). The GIDO Experience
09:00 - 09:00 | Presenter: Regina Gironés
- Abstract
Loading... -
+
P2.01-032 - A Randomized Phase Ii Trial of Selumetinib + Platinum-pemetrexed (Pem-c) in Kras Wildtype (Wt)/Unknown NSCLC: CCTG Ind219
09:00 - 09:00 | Author(s): Penelope Bradbury
- Abstract
Loading... -
+
P2.01-033 - Leptomeningeal Metastasis from Non-Small Cell Lung Cancer: A Single Center Experience in Chinese Patients
09:00 - 09:00 | Author(s): X. Wu
- Abstract
Loading... -
+
P2.01-034 - Phase I/II Trial of Weekly Nab-Paclitaxel as 2nd or 3rd Line Treatment in NSCLC Without Driver Mutations. (OLCSG1303)
09:00 - 09:00 | Presenter: Kenichiro Kudo
- Abstract
Loading... -
+
P2.01-035 - Phase II Study: Weekly Docetaxel as First Line Chemotherapy for Elderly Patients with Squamous-Cell Non-Small-Cell Lung Cancer
09:00 - 09:00 | Author(s): Sung Yong Lee
- Abstract
Loading... -
+
P2.01-036 - Symptom Trajectories During Chemotherapy Predict Overall Survival in Patients with Advanced Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: Qiuling Shi
- Abstract
Loading... -
+
P2.01-037 - Clinical Impact of Interstitial Lung Disease on Advanced Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: Hajime Oi
- Abstract
Loading... -
+
P2.01-038 - Determinants of Frailty and Treatment Toxicity in Non-Small Cell Lung Cancer Patient
09:00 - 09:00 | Presenter: Marie-Eve Boucher
- Abstract
Loading... -
+
P2.01-039 - Erythropoiesis-Stimulating Agents for Chemotherapy-Induced Anaemia in Lung Cancer: Efficacy, Toxicity and Effect on Survival
09:00 - 09:00 | Author(s): V. Xirou
- Abstract
Loading... -
+
P2.01-040 - Pemetrexed plus Platinum Chemotherapy with or Without Immunotherapy in Non-Squamous NSCLC: Descriptive Safety Analysis
09:00 - 09:00 | Author(s): Ramaswamy Govindan
- Abstract
Loading... -
+
P2.01-041 - Pemetrexed plus Platinum Chemotherapy with or Without ImmunoResponses of Bevacizumab plus Cisplatin for the Non-Squamous Non-Small-Cell Lung Cancer Patients with Malignant Pleural Effusionstherapy in Non-Squamous NSCLC: Descriptive Safety Analysis
09:00 - 09:00 | Presenter: Xue Li
- Abstract
Loading... -
+
P2.01-042 - Perioperative Chemotherapy with Pemetrexed and Cisplatin for Pulmonary LCNEC: A Case Report and Literature Review
09:00 - 09:00 | Presenter: Hong Tang
- Abstract
Loading... -
+
P2.01-043 - PD-L1 Expression, EGFR and KRAS Mutations in First-Line Therapy (1L) for Non-Small Cell Lung Cancer (NSCLC) Patients
09:00 - 09:00 | Author(s): D. Cronin-Fenton
- Abstract
Loading... -
+
P2.01-044 - The Correlation Between One Year Survival and the Affecting Factors of Lung Cancer Patients at Dr. Moewardi Hospital Surakarta
09:00 - 09:00 | Presenter: Ana Rima
- Abstract
Loading... -
+
P2.01-045 - The Efficiency of Apatinib plus S-1 as Laterline Chemotherapy for Advanced Non-Small-Cell Lung Cancer
09:00 - 09:00 | Presenter: Zhiyong Wu
- Abstract
Loading... -
+
P2.01-046 - Clinical Characteristics of Survival with De Novo Versus Relapsed Metastatic Non-Small Cell Lung Cancer
09:00 - 09:00 | Author(s): A.J.W. Gibson
- Abstract
Loading... -
+
P2.01-047 - A Phase 1 Trial of Dose Escalated BGB324 in Combination with Docetaxel for Previously Treated Advanced NSCLC
09:00 - 09:00 | Presenter: David E Gerber
- Abstract
Loading... -
+
P2.01-048 - Early Changes in Body Composition in Metastatic Non-Small Cell Lung Cancer (NSCLC) Are Predictive for Poor Overall Survival
09:00 - 09:00 | Author(s): J.H.R.J. Degens
- Abstract
Loading... -
+
P2.01-049 - Long Progression Free Survival and Overall Survival in Advanced NSCLC Patients with EGFR Mutation and Complete Response with TKI Treatment
09:00 - 09:00 | Presenter: Omar Macedo-Pérez
- Abstract
Loading... -
+
P2.01-050 - Predicting Risk of Hospitalization in Patients with NSCLC Receiving Chemotherapy Using the LCSS 3-Item Global Index (3-IGI)
09:00 - 09:00 | Presenter: Richard J Gralla
- Abstract
Loading... -
+
P2.01-051 - Randomized Study of Pemetrexed Versus Erlotinib as Maintenance Therapy in Metastatic /Locally Advanced EGFR Mutation Negative NSCLC
09:00 - 09:00 | Author(s): A. Joshi
- Abstract
Loading... -
+
P2.01-052 - Does Radiomics Improves the Survival Prediction in Non Small Cell Lung Cancer?
09:00 - 09:00 | Presenter: Ravindra Patil
- Abstract
Loading... -
+
P2.01-053 - Outcome of Clinical Management of Elderly and Younger Patients with NSCLC Inside a Private Institution (Oncosalud-AUNA)
09:00 - 09:00 | Presenter: Jose Maria Gutierrez Castañeda
- Abstract
Loading... -
+
P2.01-054 - Inclusion of Central Nervous System Metastasis in Lung Cancer Early Phase Clinical Trials
09:00 - 09:00 | Presenter: Narjust Duma
- Abstract
Loading... -
+
P2.01-055 - Examining Metabolomics as a Prognostic Marker in Metastatic Non–Small Cell Lung Cancer Patients Undergoing First-Line Chemotherapy
09:00 - 09:00 | Presenter: Desiree Hao
- Abstract
Loading... -
+
P2.01-056 - Use of Cell-Free Circulating RNA (cfRNA) Expression of PD-L1 and ERCC1 in Plasma to Monitor Response to Therapy in NSCLC
09:00 - 09:00 | Presenter: Luis E Raez
- Abstract
Loading... -
+
P2.01-057 - Activity of Pemetrexed on Wild-Type and Unknown Status EGFR Genes with Brain Metastases from Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: Yun Fan
- Abstract
Loading... -
+
P2.01-058 - Pharmacokinetic Parameter Variability of Docetaxel between Individuals and Its Relationship with Hematological Toxicity
09:00 - 09:00 | Presenter: Qisen Guo
- Abstract
Loading... -
+
P2.01-058a - Dose Serum Lactate Dehydrogenase Have a Significant Prognostic Value in Lung Cancer?
09:00 - 09:00 | Presenter: Sharareh Seifi
- Abstract
No abstract available for this presentation
-
+
P2.01-059 - Breast Metastasis from Pulmonary Cancer: A Case Report. University Hospital "Shefqet Ndroqi" Tirana Albania 2008
09:00 - 09:00 | Presenter: Fadil Gradica
- Abstract
Loading... -
+
P2.01-060 - Outcomes Following Gamma Knife Radiosurgery in Patients with Non-Small Cell Lung Cancer with Brain Metastases
09:00 - 09:00 | Presenter: Oliver Coen
- Abstract
Loading... -
+
P2.01-061 - Mode of Lung and Airway Metastasis of NSCLC: Review of Chest CT Findings
09:00 - 09:00 | Presenter: Mi Young Kim
- Abstract
Loading... -
+
P2.01-062 - Primary Lung Adenocarcinoma in the Young with Multiple Metastases: An Autopsy Report of 2 Cases
09:00 - 09:00 | Presenter: Randell Santos Arias
- Abstract
Loading... -
+
P2.01-063 - Outcomes of Patients with Oligometastatic Non-Small Cell Lung Cancer Who Were Treated with Radical Treatment
09:00 - 09:00 | Presenter: Ahmet Bilici
- Abstract
Loading... -
+
P2.01-064 - Co-Existing Mutations and Their Clinical Implications in Non-Small Cell Lung Cancer: Korean Lung Cancer Consortium (KLCC-13-01)
09:00 - 09:00 | Presenter: Bo Mi Ku
- Abstract
Loading... -
+
P2.01-065 - Clinico-Radiological and Pathological Evaluation of Lung Adenocarcinoma with Infiltration on the Computed Tomography of the Chest
09:00 - 09:00 | Presenter: Asuka Okada
- Abstract
Loading... -
+
P2.01-066 - Targeted Therapy for Lung Cancer: Liquid Biopsy or Tumor Sampling? A Case-Control Study
09:00 - 09:00 | Presenter: Zhen-Yu Ding
- Abstract
Loading... -
+
P2.01-067 - Treatment of the Patients with Oncological Emergencies with Massive Pleural Effusion at the First Hospital Visit
09:00 - 09:00 | Presenter: Kazuhiro Ito
- Abstract
Loading... -
+
P2.01-068 - Lobectomy Improve the Survival of Non-Small Cell Lung Cancer Patients with Occult Malignant Pleural Disease First Detected at Thoracotomy
09:00 - 09:00 | Presenter: Shaolei Li
- Abstract
Loading... -
+
P2.01-069 - Radiologists' Considerations to Determine the Origin of Tumor on Chest CT: Lung vs Mediastinum
09:00 - 09:00 | Presenter: Junghwa Choi
- Abstract
Loading... -
+
P2.01-070 - FAACT- Anorexia Cachexia Scale: Cut-Off Value for the Anorexia Diagnosis in NSCLC Patients
09:00 - 09:00 | Presenter: Jenny Turcott
- Abstract
Loading... -
+
P2.01-071 - Efficacy of Thoracic Radiotherapy in Oligometastatic Non-Small-Cell Lung Cancer Harboring Wild-Type EGFR After First-Line Chemotherapy
09:00 - 09:00 | Presenter: Congying Xie
- Abstract
Loading... -
+
P2.01-072 - Local Management of Oligometastasis in Non-Small Cell Lung Cancer (NSCLC)
09:00 - 09:00 | Author(s): M. Riudavets Melia
- Abstract
Loading... -
+
P2.01-073 - Prognostic Factors Analysis of Non-Small Cell Lung Cancer with Brain Metastases
09:00 - 09:00 | Presenter: Jiancheng Li
- Abstract
Loading... -
+
P2.01-074 - Wait and See: A Favorable Alternative for R-M1a and S-M1a NSCLC Patients
09:00 - 09:00 | Presenter: Ying Chen
- Abstract
Loading... -
+
P2.01-075 - Genomic Changes and Clinical Characteristics Associated with Wood-Smoke Exposure in Patients with Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: Norma Yanet Hernandez-Pedro
- Abstract
Loading... -
+
P2.01-075a - Incidence of Hippocampal Metastases in Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: Sophia Ly
- Abstract
No abstract available for this presentation
-
+
P2.01-075b - Analysis of the Safety and Usefulness of Nab-Paclitaxel Therapy in Patients with Non-Small Cell Carcinoma
09:00 - 09:00 | Presenter: I. Eriko
- Abstract
Loading... -
+
P2.01-075c - FGFR1 as an Intrinsic Resistance Mechanism in Erlotinib Treated EGFR Mutated NSCLC
09:00 - 09:00 | Presenter: Kristine Raaby Jakobsen
- Abstract
Loading... -
+
P2.01-075d - Analysis of Early Survival in Patients with Advanced Non-Squamous NSCLC Treated with Nivolumab: The Italian Expanded Access Program Experience
09:00 - 09:00 | Presenter: Hector Josè Soto Parra
- Abstract
Loading... -
+
P2.01-075e - Neutrophil to Lymphocyte Ratio Predicts Survival in Advanced NSCLC Patients Treated with Second-Line PD-1 Immune Checkpoint Inhibitors
09:00 - 09:00 | Author(s): S. Labomascus
- Abstract
No abstract available for this presentation
-
+
P2.01-075f - Detection of EML4-ALK and ROS1 Fusion Gene in NSCLC by PNA-Assisted Real-Time RT-PCR Using Fluorescent Meting Curve Analysis
09:00 - 09:00 | Presenter: Myosun Kim
- Abstract
Loading... -
+
P2.01-075g - Genotyping of EML4-ALK Fusion Gene by PNA-Assisted Real-Time RT-PCR Using Fluorescent Meting Curve Analysis
09:00 - 09:00 | Presenter: Myosun Kim
- Abstract
Loading...
first
prev
